反应 #3888170
相关文献 (1)
openreactiondata ↗doi:10.1039/C8SC04228D
反应条件: temp:0.00; pressure:0.00; stir:
来源 ID: ord-12fe0ae5b4aa400ab7fcc47482b56e51暂无可渲染的结构数据
CC(C)(CC1CCNCC1)O中间体产品
2-methyl-1-piperidin-4-ylpropan-2-ol
结构、标识符和计算性质已按 CAS 与数据库记录完成匹配。
| 中文名称 | 2-methyl-1-(piperidin-4-yl)propan-2-ol |
|---|---|
| English name | 2-methyl-1-piperidin-4-ylpropan-2-ol |
| IUPAC 名称 | — |
| CAS号 | 70724-77-5 |
| 数据库编号 | 18423428 |
| 分子式 | — |
| 分子量 | — |
产品信息
2-methyl-1-(piperidin-4-yl)propan-2-ol(CAS 70724-77-5)的产品身份、结构标识及相关反应资料,供化学中间体检索、研发和采购评估使用。
可能的应用方向
仅供专业研发与工业用途
数据库编号 18423428
安全提示
仅供专业研发与工业用途。操作前请依据供应商提供的安全数据表完成风险评估。
合成路线数据
8 条反应 · 8 篇文献
反应条件: temp:0.00; pressure:0.00; stir:
来源 ID: ord-12fe0ae5b4aa400ab7fcc47482b56e51反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: Following General Procedure E of amine alkylation, 4-(8-(bromomethyl)-9-methyl-2-(2-methyl-1H-benzo[d]imidazol-1-yl)-9H-purin-6-yl)morpholine and 2-methyl-1-(piperidin-4-yl)propan-2-ol were reacted to give 266. LCMS: M+H+=519.4 were reacted
来源 ID: ord-2bc48261306843aea0dfee69e4622ca6反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: Following General Procedure E of amine alkylation, 4-(8-(bromomethyl)-9-methyl-2-(2-methyl-1H-benzo[d]imidazol-1-yl)-9H-purin-6-yl)morpholine and 2-methyl-1-(piperidin-4-yl)propan-2-ol were reacted to give 266. LCMS: M+H+=519.4 were reacted
来源 ID: ord-ba9aace4ab5c4e14805e5a984df4572a反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: To a solution of 478 mg of 5-methoxyindole-2-carboxylic acid and 432 mg of 2-methyl-1-(piperidin-4-yl)-2-propanol in 8 mL of DMF were added 575 mg of 1-ethyl-3-(dimethylaminopropyl)carbodiimide hydrochloride and 169 mg of 1-hydroxybenzotriazole, followed by stirring at room temperature for 1 day. 0.2M aqueous hydrochloric acid was added to the reaction liquid, followed by extraction with ethyl acetate. The organic layer was washed with 0.2M aqueous sodium hydroxide solution and saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography [chloroform:methanol=1:0-24:1], and then crystallized from a mixture of ethyl acetate/diisopropyl ether to obtain 683 mg of 1-{1-[(5-methoxy-1H-indol-2-yl)carbonyl]piperidin-4-yl}-2-methylpropan-2-ol as a white crystal. followed by extraction with ethyl acetate The organic layer was washed with 0.2M aqueous sodium hydroxide solution and saturated aqueous sodium chloride solution dried over anhydrous sodium sulfate concentrated under reduced pressure The residue was purified by silica gel column chromatography [chloroform:methanol=1:0-24:1] crystallized from a mixture of ethyl acetate/diisopropyl ether
来源 ID: ord-e1384e6c2519432a86f90b80e9d21c45反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: To a solution of 1800 mg of 5-methylindole-2-carboxylic acid and 1500 mg of 2-methyl-1-(piperidin-4-yl)-2-propanol in 25 mL of DMF were added 2100 mg of 1-ethyl-3-(dimethylaminopropyl)carbodiimide hydrochloride and 1500 mg of 1-hydroxybenzotriazole, followed by stirring at room temperature for 1 day. 0.5M aqueous hydrochloric acid was added to the reaction liquid, followed by extraction with ethyl acetate. The organic layer was washed with 0.5M aqueous sodium hydroxide solution and saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography [chloroform:methanol=1:0-10:1], and then crystallized from a mixture of ethyl acetate/diisopropyl ether to obtain 2140 mg of 2-methyl-1-{1-[(5-methyl-1H-indol-2-yl)carbonyl]piperidin-4-yl}propan-2-ol as a white crystal. followed by extraction with ethyl acetate The organic layer was washed with 0.5M aqueous sodium hydroxide solution and saturated aqueous sodium chloride solution dried over anhydrous sodium sulfate concentrated under reduced pressure The residue was purified by silica gel column chromatography [chloroform:methanol=1:0-10:1] crystallized from a mixture of ethyl acetate/diisopropyl ether
来源 ID: ord-95f32f7b738142c5ae22c64ee2242768反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: To a solution of 370 mg of 5-chloroindole-2-carboxylic acid and 300 mg of 2-methyl-1-(piperidin-4-yl)-2-propanol in 8 mL of DMF were added 360 mg of 1-ethyl-3-(dimethylaminopropyl)carbodiimide hydrochloride and 250 mg of 1-hydroxybenzotriazole, followed by stirring at room temperature for 1 day. 0.5M aqueous hydrochloric acid was added to the reaction liquid, followed by extraction with ethyl acetate. The organic layer was washed with 0.5 M aqueous sodium hydroxide solution and saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography [chloroform:methanol=1:0-10:1], and then crystallized from diisopropyl ether to obtain 268 mg of 1-{1-[(5-chloro-1H-indol-2-yl)carbonyl]piperidin-4-yl}-2-methylpropan-2-ol as a white crystal. followed by extraction with ethyl acetate The organic layer was washed with 0.5 M aqueous sodium hydroxide solution and saturated aqueous sodium chloride solution dried over anhydrous sodium sulfate concentrated under reduced pressure The residue was purified by silica gel column chromatography [chloroform:methanol=1:0-10:1] crystallized from diisopropyl ether
来源 ID: ord-7f5b16ae7c984097b7e24bf329c2eab7反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: To a solution of 8.5 g of benzyl 4-(2-hydroxy-2-methylpropyl)piperidine-1-carboxylate in 120 mL of methanol was added 500 mg of 10% palladium-carbon, followed by stirring under a hydrogen atmosphere at room temperature for 1 day. Insoluble material was removed by filtration through Celite, and the filtrate was concentrated under reduced pressure to obtain 5.6 g of 2-methyl-1-(piperidin-4-yl)-2-propanol as a white solid. Insoluble material was removed by filtration through Celite the filtrate was concentrated under reduced pressure
来源 ID: ord-f9f4078cd7ed4b5f894f603b6fda5356反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: To a solution of 0.69 g (2.7 mmol) of 1-t-butoxycarbonyl-4-(methoxycarbonylethyl)piperidine (Example 22, Step 2) in 26 mL of ether at 0° C. was added dropwise 2.8 mL (8.4 mmol) of CH3MgBr (3 M in ether) and the reaction mixture was warmed slowly to rt. After stirring at rt for 6 h, the reaction was quenched by addition of 20 mL of sat'd NH4Cl solution and the mixture was stirred overnight. The mixture was extracted with ethyl acetate. The combined organic fractions were washed with sat'd NaCl solution, dried over MgSO4, filtered and the filtrate was concentrated. The residue was purified by chromatography (silica, hexanes-:ethyl acetate, 3:1) to give 0.5 g of the title compound. the reaction was quenched by addition of 20 mL of sat'd NH4Cl solution the mixture was stirred overnight The mixture was extracted with ethyl acetate The combined organic fractions were washed with sat'd NaCl solution dried over MgSO4 filtered the filtrate was concentrated The residue was purified by chromatography (silica, hexanes-:ethyl acetate, 3:1)
来源 ID: ord-18e9b361be87475c8b28a056ef5c2ec7PubChem References
以下资料来自该化合物的公开数据库参考记录。
相关产品
12 related records
CAS 3518-83-0
CAS 89585-19-3
CAS 54525-19-8
CAS 2055759-96-9
CAS 198976-43-1
CAS 1630907-10-6
CAS 5382-16-1
CAS 26228-68-2
CAS 78346-06-2
CAS 1357923-37-5
CAS 221298-00-6
CAS 1197207-57-0
询价
请提供目标规格、数量、交付地区及用途,CATO 团队将核对供应能力并回复。
